NCS Multistage's 15min chart triggers RSI Overbought and Bearish Marubozu signals.

NCS Multistage's 15-minute chart has triggered an overbought reading on the Relative Strength Index (RSI) and a bearish Marubozu candlestick pattern on August 1, 2025, at 11:15. This suggests that the stock price has risen too quickly and is no longer supported by fundamental factors, indicating a shift in market control to sellers. As a result, bearish momentum is likely to continue.

NCS Multistage Holdings, Inc. (NCSM) reported robust second-quarter (Q2) 2025 financial results, highlighting a strong start to the year. The company's CEO, Ryan Hummer, emphasized the company's performance, noting that Q2 revenue exceeded expectations by over $7 million, reaching $36 million. This performance was driven by strong Canadian market growth, with revenue for the first half of 2025 exceeding $86 million, an 18% increase over the prior year [1].

The acquisition of ResMetrics, a provider of tracer diagnostics technologies, was a significant strategic move. The company's trailing 12-month unaudited revenue was over $10 million, with an EBITDA margin of over 30%. Hummer described the acquisition as creating "the leading global tracer diagnostics business" and establishing a platform for product and service development around reservoir diagnostics [1].

NCSM's CFO, Michael L. Morrison, reported that the company's adjusted gross profit for the second quarter was $13 million, representing an adjusted gross margin of 36%. Despite this, the company's adjusted gross margin decreased from 40% in the prior year, primarily due to the mix of products sold and services provided [1].

The company's net income for the second quarter was $0.9 million, or diluted earnings per share of $0.34, an improvement compared to the second quarter net loss of $3.1 million or a loss per share of $1.21 in the prior year [1].

NCSM's full-year 2025 guidance was modestly increased to a range of $168 million to $176 million, with combined revenue guidance, including ResMetrics, of $172 million to $181 million. Combined adjusted EBITDA guidance is $22 million to $25.5 million [1].

Management cited caution for the second half of the year due to market and industry conditions, including a further decline in the U.S. rig count, a slower-than-normal rig count recovery in Canada following spring breakup, the potential for an oversupplied oil market due to an increase in OPEC plus oil supply, and ongoing uncertainties related to tariffs and trade [1].

The acquisition of ResMetrics is expected to add $4 million to $5 million of revenue and $1 million to $1.5 million of adjusted EBITDA for the last five months of 2025 [1].

Analysts' questions focused on integration synergies, market expansion, and guidance uncertainty, indicating a cautiously optimistic to neutral tone, probing for potential risks and upside in the new acquisition and macro environment [1].

References:
[1] https://seekingalpha.com/news/4476651-ncs-multistage-outlines-172m-181m-revenue-target-for-2025-amid-resmetrics-acquisition-and